Vericel Corp.
(NASDAQ : ASTM)

( )
ASTM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.98%628.331.0%$845.71m
DHRDanaher Corp. 2.13%313.450.7%$787.97m
MDTMedtronic Plc 1.82%112.250.6%$721.69m
ABTAbbott Laboratories -0.03%132.430.8%$684.68m
ISRGIntuitive Surgical, Inc. 5.16%340.490.8%$527.81m
DXCMDexCom, Inc. 6.48%558.407.8%$419.12m
BDXBecton, Dickinson & Co. 1.73%250.391.0%$383.76m
SYKStryker Corp. 2.41%260.541.3%$373.40m
BSXBoston Scientific Corp. 1.72%41.401.0%$362.00m
ALGNAlign Technology, Inc. 4.35%666.726.4%$339.55m
EWEdwards Lifesciences Corp. 3.22%115.560.4%$288.80m
AAgilent Technologies, Inc. 1.63%153.941.6%$259.09m
ZBHZimmer Biomet Holdings, Inc. 2.33%128.411.7%$232.19m
IDXXIDEXX Laboratories, Inc. 3.25%611.433.8%$226.28m
PKIPerkinElmer, Inc. (United States) 2.16%185.402.4%$173.66m

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.